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Predicting ambulation status one year after lower
extremity bypass
Philip P. Goodney, MD,a,b Donald S. Likosky, PhD,a,b and Jack L. Cronenwett, MD,a for the Vascular
Study Group of Northern New England, Lebanon and Hanover, NH
Introduction: Surgeons must weigh the morbidity of lower extremity bypass (LEB) with the likelihood of a functional
outcome postoperatively. We developed a model to predict ambulation status 1 year after LEB.
Methods: We analyzed a prospective registry of 1561 LEB procedures performed for occlusive disease (2003-2005) in
1400 patients (50 surgeons, 11 hospitals). Ambulation status was assessed preoperatively, at discharge, and at 1-year by
life-table analysis. Cox proportional hazards models were used to determine predictors of ambulation status 1 year
postoperatively.
Results: The indication for surgery was claudication in 25% and critical limb ischemia (CLI) in 75%. Claudicant patients
had higher primary (79% vs 73%, P< .001) and secondary (87% vs 81%, P< .001) graft patency rates and weremore likely
to be alive and ambulatory 1 year postoperatively (96% vs 81%, P< .001) than CLI patients. Amputation rates were 12%
for CLI patients and 1% for claudicant patients (P < .001). All claudicant patients walked before surgery, and the 95%
who survived 1 year postoperatively remained ambulatory. Preoperatively, 93% of CLI patients were ambulatory, and
88% of the survivors at 1 year remained ambulatory. The risk of dying or being nonambulatory 1 year postoperatively was
increased in patients who were nonambulatory preoperatively (hazard ratio [HR], 1.5; 95% confidence interval [CI],
1.3-1.6; P < .0001), by increasing age of 70-79 (HR, 1.8; 95% CI, 1.2-2.6; P < .007) and 80-89 years (HR, 2.3; 95%
CI, 1.5-3.7; P< .0001), by CLI (HR, 2.0; 95% CI, 1.2-3.4; P< .007), by postoperative myocardial infarction (HR, 2.5;
95% CI, 1.6-4.1; P < .001), and by major amputation (HR, 2.9; 95% CI, 2.1-4.1; P < .001). Graft thrombosis during
follow-up (HR, 1.6; 95% CI, 1.1-1.8; P < .003) and living in a nursing home preoperatively (HR, 3.5; 95% CI, 1.5-7.8;
P < .003) were independently associated with a higher risk of being nonambulatory at 1 year.
Conclusions: Ambulatory and independent living status are well preserved after LEB. Risk factors of age, preoperative
ambulatory ability, independent living status, CLI, graft patency, and amputation help to predict ambulatory status 1
year postoperatively. The likelihood of death or nonambulatory status at 1 year was <5% in patients with none of these
risk factors to nearly 50% in patients with three or more risk factors. These variables can be used to inform decision
making about whether patients should undergo LEB. (J Vasc Surg 2009;49:1431-9.)The ability to walk is a major determinant of indepen-
dent living status among elderly individuals,1-3 and loss of
this critical skill often forces elderly patients toward nursing
home admission, either temporarily or permanently.2 Al-
though several investigators have shown that intermittent
claudication4-8 or an abnormal ankle-brachial index (ABI)9
predict cardiovascular death, nonambulatory status is an
equally good10 if not better11 predictor of a morbid cardio-
vascular event. When ambulation status is threatened by
critical limb ischemia (CLI), either from rest pain or tissue
loss, the main therapy is revascularization, which is tradi-
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extremity bypass (LEB).
Many investigators have extensively studied the risk
factors that predict graft patency, limb salvage, or death,
but few have investigated the predictors of ambulation after
LEB. Further, despite its considerable affect on function
and independent living status, few investigators have exam-
ined the ability of LEB to preserve ambulation and inde-
pendent living status.12-14 Therefore, the purpose of this
study was to further refine our ability to predict preopera-
tively which patients will be ambulatory 1 year after LEB,
across community and academic centers, using our regional
quality improvement database.
METHODS
Patients and databases. We used data collected pro-
spectively by the Vascular Study Group of Northern New
England (VSGNNE), a regional cooperative quality-
improvement initiative developed in 2002, to study re-
gional outcomes in vascular surgery. Further details on this
registry have been published previously15 and are available
at www.vsgnne.org. The Institutional Review Board at
Dartmouth Medical School reviewed and approved the
study protocol.
We included only patients who underwent open in-
frainguinal bypass procedures for occlusive disease. Bypass
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targets could be above knee or below knee, popliteal, tibial,
or pedal vessels. The analysis also included patients with
concomitant endovascular procedures such as iliac stenting
at the time of LEB. LEB procedures could be performed in
an in situ fashion, with reversed vein, with vein cuffs or
adjuncts, or with prosthetic conduit.
Our unit of analysis was the patient, and the main
outcome measure was the ability to walk at 1 year after
LEB. We identified 1400 patients in our database who
underwent 1561 LEB procedures between January 1,
2003, and December 31, 2006. In patients with multiple
LEBs on the ipsilateral or contralateral extremity, we ana-
lyzed only the initial LEB procedure and measured the
main outcome measure at 1 year after the initial LEB
procedure; we did not analyze the 102 (5%) subsequent
ipsilateral or contralateral LEB procedures. Among these
subsequent procedures, 21% were a second bypass on the
same limb, whereas 79% were a bypass on the contralateral
extremity. Among the remaining 1400 patients, long-term
follow-up was not available in 215 patients (11% of the
total), and 176 (13%) had died 1 year.
Definitions. Patients were evaluated for pre-existing
medical comorbidities, and these data were prospectively
entered into our registry by trained personnel. Comorbidi-
ties included chronic obstructive pulmonary disease (med-
ical history), congestive heart failure (medical history or
documented ejection fraction 50% on preoperative test-
ing), coronary artery disease (history of angina, myocardial
infarction [MI], prior coronary intervention, or electrocar-
diography changes consistent with previous MI), chronic
renal insufficiency (creatinine 1.8 mg/dL), end-stage
renal disease (on dialysis), diabetes mellitus (medical his-
tory, designated as diet-controlled, on oral hypoglycemic
agents, or on insulin), hypertension (chart history or blood
pressure140/90), hyperlipidemia (documented by chart
medical), and prior lower extremity bypass or endovascular
therapy.
Functional status was determined preoperatively, at the
postsurgical discharge, and again at 1 year postoperatively.
Ambulation status was categorized as independently ambu-
latory, ambulatory with assistance such as a cane or a
walker, wheelchair-bound, or bedridden. For modeling
purposes, we collapsed these four categories into two,
defining ambulatory as either independently ambulatory or
ambulating with assistance. Nonambulatory patients were
in a wheelchair or bedridden. We determined the preoper-
ative living situation (home or nursing home), the indica-
tion for surgery (asymptomatic, claudication, rest pain,
tissue loss, acute ischemia), and the discharge destination
(home or nursing home). ABIs were recorded. Prior bypass
or endovascular intervention, either preoperatively or con-
comitantly, was recorded, as was prior ipsilateral or con-
tralateral amputation. Ipsilateral major amputation did not
preclude the “ambulatory” designation 1 year after surgery
if a patient walked successfully with a prosthesis.
Data collection. Trained nurses or clinical data ab-
stractors entered data prospectively on 70 clinical anddemographic variables (available at www.vsgnne.org). Re-
search analysts were blinded to patient, surgeon, and hos-
pital identity. A current version of the Social Security Death
Index and 1-year follow-up data obtained as part of
VSGNNE were used to confirm the survival status of all
patients during the first year after LEB.
Risk model construction. Our main outcome mea-
sure was the patient’s ability to ambulate, with or without
assistance, 1 year after surgery. We used life-table analysis
because not all follow-up data were obtained at exactly 1
year and to account for deaths within 1 year. Ambulation
rate was then calculated by life-table analysis, expressed as
the proportion surviving and ambulatory, either indepen-
dently or with assistance.
In univariate analysis, we first selected potential preop-
erative risk factors based on clinical judgment and previous
publications and compared each variable with the 1-year
ambulatory status. Risk factors found by univariate analysis
to be associated with value of P  .1 were then used in a
multivariate Cox proportional hazards model. This model
was used to calculate hazard ratios (HR) and 95% confi-
dence intervals (CI) for ability to ambulate 1 year after
surgery.
Cox-Snell residuals were used to predict 1-year ambu-
latory status by each patient’s risk factor profile. The pre-
dictive ability of each model was evaluated by generating an
observed/expected outcome ratio across the range of risks
identified. All analyses were performed using Excel (Mi-
crosoft, Redmond, Wash) and STATA software (Stata-
Corp, College Station, Tex).
RESULTS
Patient characteristics. Between January 1, 2003,
and December 31, 2006, 1400 patients underwent LEB at
one of the 11 centers participating in the registry. Patients
were most commonly white men, aged 70 to 80 years, who
were former or current smokers. Risk factors were typical
for such patients (Table I). Indication for surgery was
claudication in 25, whereas the remaining patients had
CLI. Most (74%) had autogenous vein conduit (Appendix,
online only).
At 1 year by life-table analysis, primary graft patency
was 72%, primary assisted patency was 82%, and secondary
patency was 84%. Compared with patients with CLI, clau-
dicant patients had higher primary (79% vs 73%, P .001)
and secondary (87% vs 81%, P  .001) patency rates.
Among survivors, the 1-year amputation rate was 1% in
claudicant patients and 12% in CLI patients (P  .001).
Amputation rates were similar across conduit types, at 9%
for autologous and 10% for prosthetic (P  .63).
Survival and ambulation. At 1 year postoperatively
by life-table analysis, 84% of patients survived to ambulate
(Fig 1), meaning that they were alive and could walk at the
1-year follow-up. Patients with claudication were signifi-
cantly more likely to survive and ambulate than the CLI
patients (96% vs 81%, P  .0001).
Ambulatory status: claudication vs CLI. All patients
with claudication were ambulatory before surgery, and only
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At the time of discharge, all patients remained ambulatory
as well; however, 21% now required assistance with ambu-
lation. At the 1-year follow-up, 4% of patients had died. All
of the survivors with claudication were ambulatory. A sim-
Table 1. Patient characteristics and univariate analysis of
ambulatory status at 1 year
Variablea Total
Unable to ambulate
P
If
variable
not present
If
variable
present
Patient characteristics
Male gender 65% 11% 6% .001
Not living home pre-op 2% 7% 24% .0001
Not ambulatory pre-op 24% 3% 20% .0001
Urgent/emergency
operation 19% 6% 14% .0001
Age 60-69 27% 9% 6% .02
Age 70-79 32% 6% 8% .024
Age 80-89 11% 7% 12% .072
Age 90-99 1% 7% 10% .016
COPD 29% 7% 10% .034
Diabetes 53% 5% 10% .003
Coronary disease 41% 7% 9% .044
Congestive heart failure 17% 6% 15% .0001
Rest pain 72% 1% 4% .001
Tissue loss 72% 1% 11% .0001
Concomitant ipsilateral
procedure
Proximal angioplasty 4% 7% 18% .003
Proximal stenting 4% 8% 18% .01
Pre-op antiplatelet use 67% 6% 8% .096
Operative characteristics
Common femoral origin 71% 11% 7% .009
AK popliteal origin 4% 7% 22% .0001
AK popliteal recipient 26% 9% 4% .001
Pedal recipient 10% 7% 11% .02
Conduit
Dacron 3% 8% 0% .067
Polytetrafluoroethylene 20% 9% 5% .037
Other nonautologous
conduit 3% 7% 23% .001
Post-op complications
Superficial wound
infection 4% 7% 14% .068
Return to OR (any
reason) 13% 6% 18% .00001
Return to OR
(thrombosis) 10% 10% 18% .017
Discharge variables
Home 75% 16% 5% .0001
Rehabilitation facility 16% 7% 11% .036
Nursing home 9% 6% 25% .0001
Independent
ambulation 54% 13% 2% .0001
Graft patent at long-term
follow-up 68% 14% 4% .0001
Deep wound infection 2% 7% 19% .01
AK, Above-knee; COPD, chronic obstructive pulmonary disease; OR, op-
erating room.
aOnly variables with value of P  .10 are included; remainder are in
Appendix (online only).ilar number of patients with claudication required assis-tance with ambulation after surgery (4%) compared with
before surgery.
Most patients with CLI were ambulatory preopera-
tively (Fig 2, B); however, compared with claudicant pa-
tients, 25% vs 5% required the assistance of a cane or a
walker (P  .001). By the time of discharge, almost half of
ambulatory patients with CLI required assistance with a
cane or walker. By the 1-year follow-up, the proportion of
surviving patients who were ambulatory was similar to
preoperative levels (93% vs 88%, P  .07). Therefore,
among survivors, 88% of patients with CLI remained am-
bulatory 1 year after surgery, slightly less than those with
claudication (88% vs 96%, P  .01).
Living status: claudication vs CLI. As expected,
nearly all (99%) claudicant patients lived at home before
surgery (Fig 3, A). A few patients (5%) were discharged to
a nursing home postoperatively. By the 1-year follow-up,
however, except for those patients who died (4%), nearly all
patients lived independently, similar to their preoperative
living status.
A larger proportion of patients with CLI lived in a
nursing home before surgery than claudicant patients (4%
vs 1%, P  .03). Patients with CLI were more likely to be
discharged to a nursing home than claudicant patients. By
the 1-year follow-up, except for those patients who died,
the distribution of patients between independent and de-
pendent living was not different before surgery and 1 year
later (Fig 3, B).
Effect of major amputation. Overall, 112 patients
underwent major amputation after LEB, and most (81%)
occurred after discharge from the index LEB procedure. All
but two amputations occurred in patients with CLI. A
thrombosed bypass graft was present in 86% of the patients
who required major amputation. Major amputation (above
knee or below knee) dramatically decreased the chances of
ambulation at 1 year (88% in patients without amputation,
62% in patients with major amputation; P  .001) and
living independently (96% in those patients without ampu-
tation, 74% in those patients with major amputation; P 
.001).
Effect of secondary procedures. We found that 11%
of patients required a revision of the initial bypass 1 year
after surgery, of which 7% were operative interventions
such as patch angioplasty and 4% were endovascular revi-
sion such as angioplasty. Ambulation rates at 1 year were
similar, regardless of whether the patient required a graft
revision (91% if no revision, 90% if revision; P  .34).
Next, we considered the number of patients who re-
quired a new LEB on the same extremity or on the con-
tralateral extremity. We found that 1 year of the initial
operation, 2% of patients (by life-table analysis) underwent
a new LEB procedure on the ipsilateral leg and that 7% of
patients underwent a contralateral LEB procedure. Ampu-
tation rates were lower in patients who did not require a
second LEB procedure, although these differences were
not statistically significant (90% vs 86%, P  .12). Ambu-
lation rates at 1 year did not differ if the repeat procedure
or in
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P  .41).
Prediction model for survival and ambulation at 1
year. We performed univariate comparisons between our
main outcome measure (ability to survive and ambulate 1
year after surgery) and each of the variables reported in
Table I. Significant relationships were observed between
several variables and ambulation status. In univariate anal-
yses, several physiologic parameters such as advanced age,
diabetes, and hypertension were associated with inability to
ambulate at 1 year. Also highly correlated with ambulatory
status at 1 year were functional parameters such as preop-
erative baseline ambulatory status and living status as well as
the presence of tissue loss.
In multivariate analysis, we considered preoperative
and postoperative variables (Table II). Preoperatively, the
risk of dying or being nonambulatory 1 year after surgery
was lowest in patients who ambulated independently before
surgery and highest in elderly patients and those with CLI.
Postoperatively, patients who underwent major amputa-
tion or sustained a MI were more likely to die or become
nonambulatory at 1 year. The likelihood of death or
nonambulatory status at 1 year varied from5% in patients
with none of these risk factors to nearly 50% in patients with
three or more risk factors (Fig 4).
Development of a prediction model for ambulation
at 1 year. Because several of the risk factors in the model
used to predict survival and ambulation at 1 year ap-
peared to reflect overall patient survival rather than
variables specifically related to ambulation, we per-
formed a subgroup analysis of those patients who sur-
vived 1 year after surgery, excluding the 176 patients
(13%) who died before the 1-year follow-up. This anal-
ysis examined the risk factors specifically related to am-
bulatory status. Because no patients with claudication
who survived to 1 year were nonambulatory, we re-
stricted this analysis to only those patients with CLI.
Many of the same variables had an effect, such as major
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Fig 1. Survival curves for all patients undergoing lowe
critical limb ischemia [CLI]). Failure is defined as deathamputation and preoperative functional status, and theeffect size was larger for these variables when they specifi-
cally predicted ambulation status alone (Table III). Sys-
temic conditions such as postoperative MI were no longer
significant when we considered only ambulation, suggest-
ing that these variables contributed more toward survival
than ambulatory ability. Graft patency was now significant
as well, supporting its importance in relation to ambulation
status.
DISCUSSION
Vascular surgeons have extensively studied the factors
associated with technical success after LEB grafts, especially
those related to patency over time.16-21 Less well studied
are the functional outcomes of LEB, such as ambulation
and independent living status. Our study of the functional
results of LEB in our regional quality-improvement data-
base identified several important risk factors associated with
the ability to ambulate 1 year later.
Several groups have previously described the functional
outcomes of LEB and examined risk factors predictive of
subsequent ambulatory status (Table IV). Abou-Zamzam
et al22 studied ambulatory status and independent living
after infrainguinal bypass in Oregon between 1980 and
1995. Their multivariate analysis confirmed the importance
of preoperative independent living and ambulatory status in
determining the functional outcomes of ambulation and
independent living at 6 months. Their review documented
that 97% of the patents who were ambulatory before sur-
gery remained ambulatory thereafter. Of the 25 patients
who were not living independently before surgery, how-
ever, only one managed to ambulate to the extent that the
patient could live independently after surgery. They con-
cluded that infrainguinal bypass performed for limb salvage
is quite successful at maintaining independent living and
ambulation but is not effective in restoring those qualities
to patients who have already lost them.
Chung et al23 found slightly different results. Only 72%
of patients in their study were able to walk 6 months after
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JOURNAL OF VASCULAR SURGERY
Volume 49, Number 6 Goodney et al 1435review failed to identify any multivariate predictors of am-
bulation and only identified the extent of forefoot gangrene
and graft patency as univariate predictors of ambulatory
status.
Finally, Taylor et al24 examined 331 patients who un-
derwent LEB. They found that impaired ambulation at
presentation, infrainguinal disease, dialysis, gangrene, and
hyperlipidemia were associated with a poor composite out-
come measure, of which ambulation status was a major
component.
Results from the VSGNNE experience are also re-
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limb ischemia.ported in Table IV. Our study offers insight from a largenumber of patients, with longitudinal examination of
functional outcomes, which has allowed multivariate
modeling and excellent descriptive detail in terms of
the risk factors associated with loss of ambulatory status.
Our rates of ambulation and independent living status
are consistent with work reported previously. Across
studies, preoperative ambulatory status appears in
three of the four prediction models, and independent
living status appears in two of the four prediction mod-
els. This emphasizes the importance of functional status
before surgery in determining functional status after
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functional status, who ambulate independently and live
independently, should be offered LEB, and our study as
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Fig 3. Living status preoperatively, at discharge, and at 1 ye
Table II. Multivariate predictors of death or failure to
ambulate at 1 year after lower extremity bypass
Variable HR (95% CI) P
Preoperative
Nonambulatory statusa 1.5 (1.3-1.6) .0001
Critical limb ischemia 2.0 (1.2-3.4) .007
Age, y
60-79 1.3 (0.8-2.2) .266
70-79 1.8 (1.2-2.6) .007
80-89 2.3 (1.5-3.7) .0001
Postoperative
Myocardial infarction 2.5 (1.6-4.1) .0001
Major AK or BK amputation 2.9 (2.1-4.1) .0001
AK, above knee; BK, below knee;CI, confidence interval;HR, hazard ratio.
aIncludes patients who could not ambulate or who ambulated only with an
assist device, such as a cane or walker.well as the work of others predicts that such patients willlikely remain ambulatory and live independently. However,
the challenge lies in determining optimal treatment for the
patient with poor ambulatory ability, nonindependent liv-
ing status, advanced age, and worrisome anatomy for long-
term graft patency. This answer is much less clear. Some
argue that primary amputation should be considered in this
setting.13 However, amputation has a very low long-term
survival rate and results in poor patient functional sta-
tus.25-27 Others argue that aggressive attempts at endovas-
cular intervention should be used in these patients,28 given
their poor risk for peripheral bypass surgery and the dismal
outcomes with primary amputation.
The role of endovascular interventions in the treatment
of CLI is evolving, however, and utilization, enthusiasm,
and results have varied over time.29,30 Future studies of the
functional outcome of alternative strategies, such as pri-
mary amputation or advanced endovascular strategies in
patients with CLI, are needed. As the Medicare population
ages and health care costs continue to rise, vascular sur-
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ble benefit in functional outcomes that matter to patients,
providers, and payers alike.
Certain patient risk factors of age, nonambulatory status,
and major amputation predicted 1-year survival and ambula-
tion as well as 1-year ambulation alone. However, we found
that two factors predictive of ambulation alone—graft throm-
bosis and preoperative nursing home residence—were not
multivariate predictors of survival and ambulation. This
finding reinforced our suspicion that certain factors, such as
graft patency and patient functional status, are more closely
correlated with ambulatory status than overall survival.
Second, we were also pleased to note that although vascular
surgeons have been criticized for their focus on graft pa-
tency, rather than functional outcomes, our results indicate
4.5%
9.4%
4.5%
9.4
0%
20%
40%
60%
10
Numb
R
is
k 
o
f N
ot
 
A
m
bu
la
tin
g 
at
 
1 
Ye
ar
 
(%
)
Predic
Observ
Fig 4. Risk of not ambulating at 1 year is shown by
predicted value from the model, and the dark bars repre
Table III. Multivariate predictors of failure to ambulate
among survivors with critical limb ischemia at 1 year after
lower extremity bypass
Variable HR (95% CI) P
Preoperative
Nonambulatory statusa 1.7 (1.4-1.8) .0001
Age
60-69 1.9 (0.9-4.1) .123
70-79 2.3 (1.1-4.7) .026
80-89 3.5 (1.6-7.8) .002
Nursing home residence 3.5 (1.5-7.8) .003
Postoperative
Graft thrombosis 1.6 (1.1-1.8) .03
Major amputation 9.8 (4.2-22.6) .0001
CI, Confidence interval; HR, hazard ratio.
aIncludes patients who could not ambulate or who ambulated only with an
assist device, such as a cane or walker.that in fact these results were highly correlated.Our work has limitations. First, no information was
available for 9% of our patients for ambulation status at
long-term follow-up. We cannot be certain that those
patients lost to follow-up are not systematically different
than those patients in whom follow-up was available 1
year after surgery. However, it is important to note that
even in a worst-case scenario, wherein all patients with
incomplete follow-up were nonambulatory, our results
would still be comparable with several other series out-
lined in Table IV.
Second, our study was not a randomized trial adjudi-
cated by impartial observers. It relied on surgeons and
research personnel to accurately self-report outcomes in the
context of a regional quality-improvement database. Al-
though this is true, the data reported to the VSGNNE
database are subject to audit using administrative and
clinic-level data, and our audits demonstrated a 99% accu-
racy in capturing the LEB procedure itself and the out-
comes of interest, such as discharge location.15
Third, our risk models use data from both preoperative
and postoperative variables to allow the most accurate
prediction of ambulation status 1 year after surgery. Al-
though only a portion of these variables will be evident to
the surgeon preoperatively, we believed it was important
that surgeons were informed of all the measurable influ-
ences on the functional outcomes, regardless of when a
particular event occurred.
Finally, our study includes patients with claudication
and CLI, and some may argue that these two populations
are too different to include side by side in a study where the
main outcome measure is ambulatory status. However, we
believe it is of value to report the ambulation status of both
groups, especially because little has been reported in re-
gards to the long-term ambulation rates of claudicant
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Patients with good functional status before LEB almost
universally maintain ambulation and independent living
status 1 year after surgery. Within our multivariate predic-
tion model, we identified preoperative ambulatory status or
living in a nursing home, CLI, increasing age 70 years,
postoperative MI, and major amputation as predictive of
death or being nonambulatory at 1 year. Low-risk patients
had excellent functional outcomes, but patients with sev-
eral of these risk factors fared poorly. Surgeons and patients
should consider these variables to inform decision making
when considering surgery in high-risk settings.
In addition, we believe surgeons can use these risk
factors to design quality-improvement efforts aimed at
improving the functional outcome of LEB. Real-world
changes guided by these risk factors might be clinical
pathways designed to prevent MI, aggressive physical ther-
apy to help patients maintain ambulatory status before and
during their hospitalization for LEB, and wound care strat-
egies designed to avoidmajor amputation. Implementation
of these strategies might decrease the effect of the risk
factors identified in our study and therefore offer the op-
portunity to achieve better functional outcomes in high-
risk patients undergoing LEB.
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BK, Below-knee; SFA, superficial femoral artery.
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characteristics with non-significant univariate associations
Variable Total
Unable to ambulate
P
If variable
not present
If variable
present
Patient characteristics
Nonwhite race 2% 7% 5% .646
Pre-op medication
Statin 58% 7% 7% .816
-Blocker 80% 8% 8% .668
Operative variables
Origin
External iliac 2% 8% 4% .525
Profunda 3% 8% 3% .21
SFA 16% 7% 10% .107
BK popliteal 5% 7% 9% .669
Recipient
SFA 1% 7% 0% .217
BK popliteal 32% 7% 8% .702
Tibioperoneal trunk 3% 7% 8% .928
Anterior tibial 11% 7% 9% .5
Posterior tibial 10% 7% 6% .486
Peroneal 6% 8% 9% .775
Anesthesia type
General anesthesia 71% 8% 7% .495
Epidural 10% 8% 6% .472
Spinal 19% 7% 9% .177
